Patents by Inventor Paul Jacob Maccabee

Paul Jacob Maccabee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods, systems, and devices for determining and visually indicating demyelinated pathways
    Patent number: 10492717
    Abstract: A method includes receiving multiple compound muscle action potential values (CMAPs), wherein each CMAP is an onset latency, a peak latency, a conduction velocity, or a response amplitude measured from a baseline; for each of the CMAPs and for each of a number parameters calculated from the CMAPs, determining a corresponding demyelinating boundary value using a normal value from a preselected population; determining whether each of the CMAPs and each of the parameters exceeds the corresponding demyelinating boundary value; determining one or more demyelinated nerve pathways based on which of the CMAPs and the parameters exceeds the corresponding demyelinating boundary value; indicating on a display which of the CMAPs and the parameters exceed the corresponding demyelinating boundary value; and displaying, in pictorial form, an anatomical diagram indicating the demyelinated nerve pathways.
    Type: Grant
    Filed: November 4, 2014
    Date of Patent: December 3, 2019
    Assignee: The Research Foundation of State University of New York
    Inventors: Paul Jacob Maccabee, Lawrence Philip Eberle
  • METHODS, SYSTEMS, AND DEVICES FOR DETERMINING AND VISUALLY INDICATING DEMYELINATED PATHWAYS
    Publication number: 20160270709
    Abstract: A method includes receiving multiple compound muscle action potential values (CMAPs), wherein each CMAP is an onset latency, a peak latency, a conduction velocity, or a response amplitude measured from a baseline; for each of the CMAPs and for each of a number parameters calculated from the CMAPs, determining a corresponding demyelinating boundary value using a normal value from a preselected population; determining whether each of the CMAPs and each of the parameters exceeds the corresponding demyelinating boundary value; determining one or more demyelinated nerve pathways based on which of the CMAPs and the parameters exceeds the corresponding demyelinating boundary value; indicating on a display which of the CMAPs and the parameters exceed the corresponding demyelinating boundary value; and displaying, in pictorial form, an anatomical diagram indicating the demyelinated nerve pathways.
    Type: Application
    Filed: November 4, 2014
    Publication date: September 22, 2016
    Applicant: The Research Foundation of State University of New York
    Inventors: Paul Jacob Maccabee, Lawrence Philip Eberle